Bioequivalence Study of 3 mg Glimepiride Tablet in Indonesia Healthy Subjects
Status:
Completed
Trial end date:
2021-01-06
Target enrollment:
Participant gender:
Summary
The study was conducted toinvestigate whether the bioavailability of 3 mg Glimepiride Tablet
Manufactured by PT. Harsen Laboratories was bioequivalent to the reference product, 3 mg
Amaryl® Tablet Manufactured by PT. Aventis Indonesia Pharma, Indonesia.